The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1973, 110: 742-751.
Copyright © 1973 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, L. M.
Right arrow Articles by Steinberg, A. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Parker, L. M.
Right arrow Articles by Steinberg, A. D.

The Antibody Response to Polyinosinic · Polycytidylic Acid

Leroy M. Parker and Alfred D. Steinberg

Arthritis and Rheumatism Branch, National Institute of Arthritis, Metabolism and Digestive Diseases, Bethesda, Maryland 20014

Abstract

The antibody response to the synthetic double-stranded RNA polyinosinic·polycytidylic acid (rI·rC) was investigated in mice and rabbits. Mice developed an early, largely IgM, antibody response of short duration after a single injection of rI·rC in aqueous solution. The magnitude of this response was unaffected by complexing rI·rC to a protein carrier. Relative tolerance rather than increased amounts of antibody followed subsequent injections of rI·rC. However, there was a shift in antibody class to IgG. When rI·rC was given in Freund's adjuvant prolonged IgG antibody responses occurred with peaks appearing 2 or more weeks after immunization. Administration of rI·rC complexed to an immunogenic protein carrier in adjuvant resulted in highest (IgG) antibody levels. The magnitude of enhancement by carrier was greater in rabbits (10- to 100-fold) than in mice (3- to 10-fold). Inbred strains of mice were separable into "high" and "low" responding strains when rI·rC was given either in aqueous solution or in adjuvant. Low responders could be made high responders by complexing rI·rC to a carrier and immunizing in adjuvant. These studies suggest that the immunogenic properties of rI·rC are similar to other materials, and that differences are also apparent.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1973 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1973 by The American Association of Immunologists, Inc. All rights reserved.